We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
151
Wedgewood Partners
Missouri
– -$84K -122,750 Closed
HA
152
Havens Advisors
New York
– -$84K -122,301 Closed
LPL Financial
153
LPL Financial
California
– -$81K -116,860 Closed
UCFA
154
United Capital Financial Advisors
Texas
– -$75K -108,707 Closed
CCM
155
Chiron Capital Management
Florida
– -$74K -107,333 Closed
PNC Financial Services Group
156
PNC Financial Services Group
Pennsylvania
– -$74K -106,547 Closed
ERSOT
157
Employees Retirement System of Texas
Texas
– -$72K -104,300 Closed
AllianceBernstein
158
AllianceBernstein
Tennessee
– -$70K -101,737 Closed
MCM
159
McRae Capital Management
New Jersey
– -$70K -100,892 Closed
SS
160
Sunbelt Securities
Texas
– -$69K -100,296 Closed
Qube Research & Technologies (QRT)
161
Qube Research & Technologies (QRT)
United Kingdom
– -$69K -100,099 Closed
HHGC
162
Hunting Hill Global Capital
New York
– -$69K -100,000 Closed
RJFSA
163
Raymond James Financial Services Advisors
Florida
– -$61K -88,676 Closed
AIM
164
Achmea Investment Management
Netherlands
– -$60K -87,695 Closed
ANI
165
American National Insurance
Texas
– -$60K -86,545 Closed
IMPI
166
Ilmarinen Mutual Pension Insurance
Finland
– -$59K -86,000 Closed
LOAMU
167
Lombard Odier Asset Management (USA)
New York
– -$59K -85,000 Closed
Macquarie Group
168
Macquarie Group
Australia
– -$57K -83,028 Closed
NRS
169
Neville Rodie & Shaw
New York
– -$57K -82,984 Closed
PGFC
170
Peapack-Gladstone Financial Corp
New Jersey
– -$57K -82,939 Closed
MNBTD
171
Moody National Bank Trust Division
Texas
– -$57K -82,807 Closed
PCM
172
Parsons Capital Management
Rhode Island
– -$56K -81,825 Closed
TIM
173
Thompson Investment Management
Wisconsin
– -$56K -80,999 Closed
CWM
174
CIBC World Markets
New York
– -$54K -78,366 Closed
DC
175
Davenport & Co
Virginia
– -$54K -77,794 Closed
5 6
7
8 9

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.